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Abstract
Background: Previous studies in aging animals have shown that amyloid-beta protein (Aβ) accumulates and its transporters,
low-density lipoprotein receptor-related protein-1 (LRP-1) and the receptor for advanced glycation end products (RAGE) are
impaired during hydrocephalus. Furthermore, correlations between astrocytes and Aβ have been found in human cases of
normal pressure hydrocephalus (NPH) and Alzheimer's disease (AD). Because hydrocephalus occurs frequently in children, we
evaluated the expression of Aβ and its transporters and reactive astrocytosis in animals with neonatal hydrocephalus.
Methods: Hydrocephalus was induced in neonatal rats by intracisternal kaolin injections on post-natal day one, and severe
ventriculomegaly developed over a three week period. MRI was performed on post-kaolin days 10 and 21 to document
ventriculomegaly. Animals were sacrificed on post-kaolin day 21. For an age-related comparison, tissue was used from previous
studies when hydrocephalus was induced in a group of adult animals at either 6 months or 12 months of age. Tissue was
processed for immunohistochemistry to visualize LRP-1, RAGE, Aβ, and glial fibrillary acidic protein (GFAP) and with
quantitative real time reverse transcriptase polymerase chain reaction (qRT-PCR) to quantify expression of LRP-1, RAGE, and
GFAP.
Results: When 21-day post-kaolin neonatal hydrocephalic animals were compared to adult (6–12 month old) hydrocephalic
animals, immunohistochemistry demonstrated levels of Aβ, RAGE, and LRP-1 that were substantially lower in the younger
animals; in contrast, GFAP levels were elevated in both young and old hydrocephalic animals. When the neonatal hydrocephalic
animals were compared to age-matched controls, qRT-PCR demonstrated no significant changes in Aβ, LRP-1 and RAGE.
However, immunohistochemistry showed very small increases or decreases in individual proteins. Furthermore, qRT-PCR
indicated statistically significant increases in GFAP.
Conclusion: Neonatal rats with and without hydrocephalus had low expression of Aβ and its transporters when compared to
adult rats with hydrocephalus. No statistical differences were observed in Aβ and its transporters between the control and
hydrocephalic neonatal animals.
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Background
Hydrocephalus is a condition characterized by an exces-
sive build up of cerebrospinal fluid (CSF) in the cerebral
ventricles. This condition is most frequently found in chil-
dren but also occurs in aged adults. Practically all forms of
hydrocephalus exhibit impairment in CSF flow and
absorption. This occurs in extraventricular (communicat-
ing) hydrocephalus, for example, when meningitis causes
fibrosis and reduces CSF flow through the subarachnoid
space[1]; it occurs in intraventricular (obstructive) hydro-
cephalus when a tumor or congenital dysplasia physically
blocks any portion of the cerebral ventricles (often the
most narrow regions such as the cerebral aqueduct of Syl-
vius) causing the proximal parts of the ventricular system
to dilate. In any case, the resulting reduced CSF flow
diminishes the natural CSF function of maintaining
homeostasis and leads to various neurological deficits [2-
7]. Interruption in normal CSF flow pathways create a
deficiency in the ability of the CSF to clear toxic sub-
stances from the brain[8,9]. In particular, one important
substance affected by impaired clearance is amyloid-beta
protein (Aβ). Accumulation of Aβ is associated with
Alzheimer-type dementia and is commonly found in the
CSF of adults with normal pressure hydrocephalus (NPH)
and in brain tissue from adult rat models of this disorder.
[7,10-16].
Although the prevalence of neonatal hydrocephalus is rel-
atively high, no studies have examined protein clearance
mechanisms in children with hydrocephalus or immature
experimental animals with this disorder. Based on the
findings in the adult literature, we hypothesized that
impaired clearance of Aβ also occurs in the neonatal
hydrocephalic brain and is accompanied by alterations in
Aβ transporters. The low-density lipoprotein receptor-
related protein-1 (LRP-1) is believed to be the major trans-
porter of Aβ from the brain parenchyma into the blood-
stream, while the receptor for advanced glycation end
products (RAGE) delivers Aβ into the brain from the vas-
culature[14]. Furthermore, adult studies have shown a
correlation between astrocytes and Aβ in cases of NPH
and AD [17-26]. While GFAP labeled astrocytes are com-
monly increased in hydrocephalus of all ages, probably in
response to a wide variety of injury mechanisms
(reviewed in[4,5,19,27,28]), these astrocytes could also
be related to Aβ clearance. For that reason, we hypothe-
sized that there would be an association between Aβ and
astrocytes with the progression of hydrocephalus.
The present study has examined LRP-1, RAGE, Aβ, and
GFAP in neonatal animals after intraventricular (obstruc-
tive) hydrocephalus was induced by kaolin injections into
the cisterna magna at 1 day of age and ventriculomegaly
had progressed until 21 days of age.
Methods
Animals
Time-pregnant Sprague Dawley rats were purchased from
Charles River, (Wilmington, MA, USA) and delivered to
the University of Utah on the 19th day of gestation. The
dam and litter were housed on a 12-h light/dark cycle
throughout the protocol. At birth (approximately 21 days
of gestation) pups were divided into two groups: sham
control (n = 10), and hydrocephalic (n = 10). Five animals
from each group were analyzed by immunohistochemis-
try and the other five animals in each group were analyzed
by qRT-PCR. All pups remained with the dam until sacri-
fice on post-kaolin day 21. In addition, tissues from adult
rats for age-related comparisons were obtained from pre-
vious studies, i.e. 6 month old kaolin injected rats[29] and
12 month old kaolin-injected rats[15]. All animal experi-
ments were conducted in accordance with the guidelines
of the NIH Care and Use of Laboratory Animals and
approved by the University of Utah (neonatal animals),
Wayne State University (6 month animals), and the Inter-
national Neuroscience Institute, Hannover, Germany (12
month animals). All efforts were made to minimize dis-
comfort and the number of animals used.
Surgical induction of obstructive hydrocephalus
Kaolin induction of hydrocephalus was performed on
post-natal day one using aseptic techniques as described
previously[30]. Anesthesia was achieved by hypothermia
on a bed of ice since newborn rats have no thermoregula-
tory ability. Once the animal reached a surgical plane of
anesthesia (loss of knee-jerk reflexes), the dorsal surface of
the skull and the cervical musculature were exposed
through a midline incision that extended from the center
of the skull to the end of the second cervical vertebra. The
scalp, membranous soft tissue, and cervical musculature
were reflected, exposing the occipital bone, the dorsal por-
tion of the C1 vertebra, and the atlanto-occipital mem-
brane which covers the 1 mm interval between those two
bones. A 30-gauge needle attached to a 1.0 ml syringe con-
taining 25% kaolin in sterile saline was inserted through
the atlanto-occipital membrane and the dura mater into
the cisterna magna. CSF was allowed to escape and
thereby compensated for the injected volume of kaolin.
Approximately 25 μl of kaolin was administered at a rate
of 6 μl/sec. Following the injection, the underlying mus-
cles were closed with 7-0 absorbable suture and the skin
closed with 7-0 Prolene suture. The animal was taken off
the ice bath and slowly warmed. Once the pup became
active and responsive, exhibiting normal knee jerk
reflexes, it was returned to the dam and litter. Sham con-
trol animals underwent identical procedures used for kao-
lin induction, but sterile saline was injected instead of
kaolin.Cerebrospinal Fluid Research 2009, 6:4 http://www.cerebrospinalfluidresearch.com/content/6/1/4
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Magnetic resonance imaging
On post-injection day 10, magnetic resonance imaging
(MRI) using T2-weighted images was employed to con-
firm or rule out ventriculomegaly. The sham injected and
kaolin injected animals were anesthetized with 1–3% iso-
flurane through a ventilator which included self-excavat-
ing components (Harvard Apparatus part # 723011 and
723026, Holliston, Massachusetts, USA) and placed in the
prone position on a cradle with gauze padding around the
pup for warmth while in the magnet. All measurements
were performed on a 7.0-Tesla horizontal-bore animal
MRI scanner (Bruker Biospec, Billerica, Massachusetts,
USA) with a 12-cm-bore actively shielded gradient coil set
capable of producing magnetic field gradients of up to
600 mT/m. For homogeneous radiofrequency (RF) excita-
tion, a 7.2-cm-inner-diameter whole-body birdcage RF
coil and a 3.0 cm-diameter surface coil were respectively
used for transmission and reception, with active RF
decoupling to avoid signal interference. Once the pups
regained consciousness they were returned to the dam.
On post-kaolin day 21, a second MRI was performed prior
to sacrifice for ventricular size comparison, using the pro-
cedures described previously.
Ventriculomegaly was quantified from the MRI images
using the Evan's ratio. This measurement is used routinely
in clinical practice and is calculated from coronal slices as
the ventricular width divided by the brain width at the
level of the foramina of Monro. Statistical comparisons
between control and hydrocephalic groups were per-
formed with Student's t-test.
Immunohistochemistry
On post-injection day 21 immediately following the MRI,
5 animals from each neonatal group (saline control and
hydrocephalic) to be analyzed by immunohistochemistry
were anesthetized with Nembutal (120 mg/kg, IP) and
perfused transcardially with 4% buffered paraformalde-
hyde. Prior to paraffin embedding, hydrocephalic brains
were injected with a solution of 4% agar in dH2O in order
to provide support to the thinned and fragile cortical
mantle, as described previously[27]. The tissue was
embedded according to routine protocols, sectioned in
the coronal plane at a thickness of 15 μm, and sections
mounted at 20 μm intervals on glass slides.
All slides were rehydrated prior to immunohistochemical
staining. Tissue sections for immunohistochemistry stain-
ing of RAGE, LRP-1, and GFAP underwent antigen
retrieval by placing slides in a steamer for 20 min with 10
mM citrate buffer (pH 6.0), preheated to 90–100°C. The
slides were cooled for 20 min in the buffer and washed in
0.01 M PBS. Following antigen retrieval, the tissue sec-
tions were quenched with 3% H2O2 for 20 min at room
temperature to eliminate endogenous peroxidase activity
and then washed with distilled water.
For RAGE staining, serum-free protein blocker was added
for 5 min and drained. Primary RAGE antibody (Affinity
Bioreagents, Golden, Colorado, USA) was applied at a
dilution of 1:100 at room temperature for 2 h and then
washed with PBS. Secondary anti-rabbit IgG biotinylated
antibody (1:200, Vector Laboratories, Burlingame, Cali-
fornia, USA) was added for 45 min at room temperature
and then rinsed with PBS. For primary antibody detection,
sections were treated with avidin-biotin complex (ABC
Kit, Vector Laboratories) for 30 min, and then rinsed with
PBS. Lastly, the sections were developed with diami-
nobenzidine (DAB Kit, Vector Laboratories) for 5 min and
rinsed with PBS. Sections were counterstained with cresyl
violet. Staining for LRP-1 (1:100, Orbigen San Diego, CA,
USA) and GFAP (1:500, Dako Cytomation, Glostrup,
Denmark) followed the same procedures as for RAGE.
Tissue sections for Aβ(1–42) staining underwent antigen
retrieval with 10% formic acid at a pH of 1.8 for 20 min at
room temperature. Sections were rinsed with distilled
water and quenched with 3% H2O2 for 20 min at room
temperature and rinsed again with distilled water. 1%
normal goat serum was used as a blocking agent for 5 min
and drained. Primary Aβ(1–42) antibody (1:100, Affinity
Bioreagents) was applied for 2 h at room temperature and
washed with PBS. Secondary anti-rabbit IgG biotinylated
antibody (1:200, Vector Laboratories) was added for 1 h
at room temperature and washed with PBS. Following the
secondary antibody, ABC was added for 30 min, washed
with PBS, and developed with DAB. Sections were coun-
terstained with cresyl violet.
All tissue was analyzed with light microscopy using
bright-field optics. Analysis included qualitative observa-
tions of the immunoreactivity of GFAP, and identification
of positively-stained RAGE, LRP-1 and Aβ proteins in the
cerebral cortex and hippocampus. Subjective judgments
were made by two microscopists on the presence or
absence of immunolabeling, based on previous reports of
the light microscopic appearance of these mark-
ers[14,15,27].
Quantitative real time (qRT)- PCR
On post-injection day 21, animals to be analyzed by qRT-
PCR were sacrificed with 120 mg/kg of Nembutal i.p.
immediately following MRI. The parietal cortex and the
hippocampus were dissected, placed into individual
micro-centrifuge tubes, and immediately frozen in liquid
N2. Tissue was stored at -80°C until needed for analysis.
Total RNA was extracted from frozen parietal cortex and
hippocampal tissue using the Nucleospin RNA II miniCerebrospinal Fluid Research 2009, 6:4 http://www.cerebrospinalfluidresearch.com/content/6/1/4
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columns (Clontech, Mountain View, CA, USA). Samples
were DNAse treated according to manufacturer's specifica-
tions to ensure removal of DNA. RNA quality and concen-
tration were analyzed using the Thermo Scientific
NanoDrop™ 1000 Spectrophotometer (Thermo Fisher
Scientific, Waltham, Massachusetts, USA) and subse-
quently reverse transcribed using the SuperScript First-
Strand Synthesis System for qRT-PCR (Invitrogen,
Carlsbad, California, USA) as instructed by the supplier.
Real-time PCR was performed with each sample in repli-
cates of four with the ABI Prism 7900HT Sequence Detec-
tion System using TaqMan Gene Expression Assays for
LRP-1 (Rn01160459_g1), RAGE (Rn00584249_m1), and
GFAP (Rn00566603_m1) (Applied Biosystems, Foster
City, California, USA). Glyceraldehyde-3-phosphate
dehydrogenase (Rn99999916_s1) was used as a reference
gene.
Relative expression levels were determined using the com-
parative Ct method as used in previous studies[31].
Briefly, values were presented as 2-(Δ Ct) where the Δ Ct
value equals the Ct of the gene of interest minus the Ct of
the internal control. Results were regarded as statistically
significant with a 95% confidence interval (P  < 0.05)
using the Student's t test.
Results
MRI imaging
No animals that received saline injections into the cis-
terna magna developed ventriculomegaly (Fig. 1A). Ani-
mals that received kaolin injections into the cisterna
magna developed hydrocephalus within a few days which
was severe by 21 days (Fig 1B). Grossly, the lateral ventri-
cles enlarged more than the third ventricle, which
enlarged more than the fourth ventricle. The septum pel-
lucidum was also obliterated and there was a large com-
munication across the midline between the two lateral
ventricles. The cerebral aqueduct was normal in the saline
controls (Fig 1C) but in the hydrocephalic animals was
expanded caudally creating a possible communication to
the subarachnoid space (SAS) that overlies the dorsal sur-
face of the midbrain (Fig 1D). The expansion of the cere-
bral ventricles was reflected in the Evan's ratios. Student's
t-test showed a significant increase (P < 0.001) when com-
pared to the control group (Fig. 2).
Immunohistochemistry of amyloid-β protein and 
transporters
LRP-1, RAGE, and Aβ were qualitatively evaluated based
on the presence of their respective antibody reactions in
three different areas: choroid plexus, cerebral cortex, and
hippocampus, where those proteins have been previously
shown to be located in aged adults with NPH and aged
rats with hydrocephalus[13-15,32]. Aβ immunostaining
(Fig. 3) was present in the choroid plexus of the 21-day
hydrocephalic animals where the positive labeling was
prominent in the epithelial cells. This was not seen the
choroid plexus of saline controls. No trace of Aβ could be
found in the neurons or around the blood vessels of the
cerebral cortices and hippocampi in 21-day normal con-
trol or age-matched hydrocephalic animals.
LRP-1 immunostaining in 21-day normal control and
aged-matched hydrocephalic animals (Fig. 4) showed
positive labeling occurring in the choroid plexus along the
apical surface and throughout the cytoplasm of the epi-
thelial cells in both groups. In the 21-day hydrocephalic
animals LRP-1 labeling appears denser in central regions
of the cell. In the cerebral cortex, as described in the cap-
tion for Figure 4, LRP-1 labeling in hydrocephalic animals
was compared to both a normal adult LRP-1-positive con-
trol and 21-day saline-injected controls. There were mini-
mal traces of LRP-1 in the cortices of control animals.
Although sections exhibited considerable non-specific
labeling of neurons and glial cells, labeling occurred in
the endothelium of microvessels and in the neuropil adja-
cent to these structures. In the hydrocephalic animals,
there was a slight increase in LRP-1 labeling in the vascu-
lature of layer IV. In contrast to the cortex, the hippocam-
pus of hydrocephalic animals exhibited slight decreases in
LRP-1 labeling. The blood vessels along the hippocampal
fissure and in the pyramidal layer of the hippocampus in
the control animals were positively stained with LRP-1;
none of this labeling was found in the hydrocephalic
group.
Positive antibody staining for RAGE (Fig. 5) appeared
along the apical surface and throughout the cytoplasm of
the epithelial cells in the choroid plexus of both the nor-
mal control and aged-matched hydrocephalic animals.
When examining the cerebral cortex of the saline control
animals, RAGE immunostaining was found around the
blood vessels in layers II, III, and IV, but there was no trace
of RAGE in the cortex of the hydrocephalic animals. More-
over, similar to LRP-1, non-specific labeling was found in
the neurons and glial cells in the cortices of both animals.
The hippocampus in both the 21 day saline controls and
the hydrocephalic animals exhibited the presence of
RAGE around the microvessels but there was no noticea-
ble difference between the two groups.
Reactive astrocytosis in neonatal-onset hydrocephalus
Qualitative analysis for GFAP (Fig. 6) was based on the
relative numbers of immunoreactive cells as well as the
cellular morphology of the astrocyte. Resting astrocytes
present a small cell body that extends thin highly-
branched processes, whereas reactive astrocytes exhibit a
large cell body with thick darkly stained processes. Resting
astrocytes were found in the control animals throughout
the cerebral cortex and hippocampus. However, in theCerebrospinal Fluid Research 2009, 6:4 http://www.cerebrospinalfluidresearch.com/content/6/1/4
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hydrocephalic animals, there was a considerable increase
in the number of reactive astrocytes throughout all six lay-
ers of the cerebral cortex and in the pyramidal cell layer of
CA1-CA3 and the granular cell layer in the dentate gyrus
in the hippocampus. There were no traces of astrocytes in
the choroid plexus of either group.
Quantitative RT-PCR
Quantitative real time RT-PCR data (Figure 7) showed
that in both the parietal cortex and the hippocampus of
the hydrocephalic animals, there were no statistical differ-
ences in LRP-1 and RAGE between hydrocephalic animals
and age-matched sham controls (P > 0.05). Mean LRP-1
mRNA expression was 98 ± 15% of control in the parietal
cortex of the hydrocephalic animals and 75 ± 8% of the
control in the hippocampus. The mean RAGE mRNA
expression exhibited an increase of 189 ± 58% in the pari-
etal cortex of the hydrocephalic animals and 87 ± 12% of
the control in the hippocampus. In contrast, GFAP in the
parietal cortex and hippocampus revealed a significant
increase (P < 0.05). In hydrocephalic animals, the mean
GFAP mRNA expression showed an increase of 454 ±
Representative coronal slices of T2-weighted MRI images comparing 21 day post-saline controls (A, C) to 21 day post-kaolin  hydrocephalic brains (B, D) Figure 1
Representative coronal slices of T2-weighted MRI images comparing 21 day post-saline controls (A, C) to 21 
day post-kaolin hydrocephalic brains (B, D). The hydrocephalic brains exhibited a dramatic increase in size of the lateral 
ventricles (LV), as well as the gross distortion of the caudate putamen (CP) and septum (S) following kaolin injections. The 
periventricular white matter (WM) appears to be thinned, stretched, and detached from the overlying cortical grey matter by 
either expansion of the lateral ventricle or edematous tissue. Additionally, image D demonstrates the cerebral aqueduct (CA) 
expanding caudally creating a possible communication to the subarachnoid space (SAS) that overlies the dorsal surface of the 
midbrain.Cerebrospinal Fluid Research 2009, 6:4 http://www.cerebrospinalfluidresearch.com/content/6/1/4
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140% and 308 ± 60% for the parietal cortex and hippoc-
ampus, respectively. Values are expressed as average com-
parative Ct values plus or minus the standard error of the
mean.
Amyloid-β protein and transporters in adult hydrocephalus
Immunohistochemical results for Aβ, LRP-1, and RAGE in
adult hydrocephalic animals differed from those of the
neonatal hydrocephalic animals. There was a substantial
increase of Aβ and RAGE in the cortex (Fig. 3 and 5 respec-
tively). LRP-1 in the adult rat was expressed around the
blood vessels in the cortex (Fig. 4). On the other hand,
RAGE (Fig. 5) and Aβ (Fig 3) were highly expressed
around the blood vessels in the pyramidal cell layer, the
granular cell layer of the dentate gyrus, and along the hip-
pocampal fissure of the hippocampus. LRP-1 was mini-
mally expressed in the hippocampus. The results for both
adult and neonatal rats are summarized in Table 1.
Discussion
In summary, intraventricular obstructive hydrocephalus
induced in one day old rats created a severe state of ven-
triculomegaly during the 3-week post-induction period. It
was apparent from both the MRI images and the histology
sections that this severity caused dramatic thinning of the
cortical mantle, loss of periventricular white matter, diso-
rientation and shrinkage of cortical pyramidal cells, com-
pression of the caudate-putamen and septum. For age-
related comparisons, 21-day old hydrocephalic animals
were compared to adult (6–12 month old) hydrocephalic
animals; immunohistochemistry revealed levels of Aβ,
RAGE, and LRP-1 that were substantially lower in the
younger animals. Conversely, GFAP expression was ele-
vated in both young and old hydrocephalic animals.
When 21-day post-kaolin hydrocephalic animals were
compared to age-matched controls, immunohistochemis-
try showed relatively small increases and decreases in
Graph representing ventricular size, expressed as the mean Evan's ratios of the two groups Figure 2
Graph representing ventricular size, expressed as the mean Evan's ratios of the two groups. The ventricles of the 
hydrocephalic group (n = 5) were significantly increased in size (*, P < 0.001) when compared to the saline controls (n = 5).
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individual proteins. The insignificance of these small
changes is addressed more appropriately by qRT-PCR,
which demonstrated no statistical differences in Aβ, LRP-
1 and RAGE expression. In contrast, qRT-PCR also showed
statistically significant increases in GFAP.
It is important to understand that when comparing neo-
natal to adult histology there are considerable differences
in the appearance of the stains. When performing immu-
nohistochemistry on the neonatal tissue for Aβ, LRP-1,
and RAGE, we experienced great difficulty eliminating
non-specific staining. This includes the dark brown out-
line around the neurons in figures 4 and 5, as well as the
brown background of the cytoplasm in figures 3, 4, 5, 6.
Rigorous attempts were made to identify the appropriate
concentrations for each antibody to reduce the back-
ground stain but were relatively ineffective. Positively-
labeled proteins can be characterized by small punctuate
particles as well as diffuse profiles. Further immunoab-
sorption experiments with authentic (purified) epitopes
could help overcome problems with non-specific labe-
ling.
Severity of hydrocephalus
The extent of ventriculomegaly and its effects on sur-
rounding brain tissue have been described in other neona-
tal and juvenile models with expandable skulls[2,27,33-
35], and the degree of tissue distortion is far greater than
that seen in adult animals with fixed cranial sutures and
non-expandable skulls[4,29,36-43]. Included in the latter
category are the animals from studies by Klinge et al[15]
and the human cases presented by Donahue et al[14] that
demonstrated impaired amyloid protein clearance. Thus,
our protein clearance findings may be different from pre-
vious reports because they occurred in a setting of more
profound ventriculomegaly. However, because minimal
labeling of transporters occurred in both control and
hydrocephalic brains, it appears likely that the Aβ clear-
ance system is not functional in neonatal rats. Thus,
impairments cannot be detected in a transport system that
does not have fully functional transporters. It is also well
known that with severe hydrocephalus cerebral blood
flow is decreased by at least 60%[44,45]. These decreases
in cerebral blood flow could create ischemic conditions
that dramatically affect Aβ transporters. Furthermore,
Photomicrographs representing amyloid beta immunohistochemistry of an adult control animal that is positively stained with  Aβ antibody(positive control; A, E), 21-day saline controls (B, C, D), and age-matched hydrocephalic animals (F, G, H) Figure 3
Photomicrographs representing amyloid beta immunohistochemistry of an adult control animal that is posi-
tively stained with Aβ antibody(positive control; A, E), 21-day saline controls (B, C, D), and age-matched 
hydrocephalic animals (F, G, H). In the adult tissue at higher magnification (A, E), positive Aβ labeling can be seen as punc-
tate or more diffuse profiles within and adjacent to the walls of capillaries. In the choroid plexus of neonatal animals, positive 
Aβ staining, characterized by dark brown punctate particles (arrows) in individual cells, was only seen in hydrocephalic animals. 
In the cortex and hippocampus, no Aβ labeling was found in either 21-day hydrocephalic animals (G, H) or age-matched con-
trols (C, D). In A, E, and F, the inset represents a higher magnification to show the punctate character of some Aβ labeling. 
Scale bar = 25 μm.Cerebrospinal Fluid Research 2009, 6:4 http://www.cerebrospinalfluidresearch.com/content/6/1/4
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since Aβ can enter the brain from the bloodstream[46], it
is possible that less Aβ is delivered directly to the neuropil
in an ischemic hydrocephalic brain. We saw very little evi-
dence of RAGE expression and without the mechanism of
transport into the brain, Aβ cannot accumulate. Finally, it
is also possible that the severity of the hydrocephalus
caused a decrease in neuronal amyloid precursor protein
expression and that might have caused a reduction in Aβ
production. It will be interesting to repeat the present
study in animals with less severe hydrocephalus.
Expression of transport proteins
Previously, Silverberg et al[32] and Donahue et al[14]
have shown that there is an accumulation of Aβ in
patients with adult onset hydrocephalus and Alzheimer's
disease (AD) due to a deficiency of Aβ clearance mecha-
nisms. Klinge et al[15], performed their studies in adult
animals at 1 year of age, and showed a significant increase
in Aβ around the blood vessels and the neuropil com-
pared to non-hydrocephalic age-matched controls but no
change was reported in the choroid plexus. The LRP-1 pro-
tein levels substantially decreased around the blood ves-
sels of the cortex and hippocampus Klinge et al [15] and
RAGE protein levels increased around the microvascula-
ture of the cortex and hippocampus Donahue et al[14].
These levels were proportional to the severity of hydro-
cephalus.
RAGE expression in the brain is reported to increase dur-
ing development when it interacts with amphoterin
(HMBG-1) to induce neurite outgrowth and then
decreases with maturation[47]. These changes have been
observed in rats up to 12 months and then expression
subsequently increases dramatically during aging. Thus
RAGE is very age dependent in its expression.
Photomicrographs representing LRP-1 immunohistochemistry of an adult control animal that is positively stained with LRP-1  (positive control; A, E), 21-day saline controls (B, C, D), and age-matched hydrocephalic animals (F, G, H) Figure 4
Photomicrographs representing LRP-1 immunohistochemistry of an adult control animal that is positively 
stained with LRP-1 (positive control; A, E), 21-day saline controls (B, C, D), and age-matched hydrocephalic 
animals (F, G, H). Black arrows represent blood vessels that are positively stained with LRP-1 proteins. These are character-
ized by either dark brown punctate particles (D, G) or diffused profiles (A, B, C, F). The asterisks represent non-specific stain-
ing of neuron and glial cell bodies. At higher magnification (E) positive LRP-1 labeling can be seen both within the endothelial 
lining (black arrow) of a capillary deep within the cerebral cortex, as well as in the neuropil immediately adjacent (yellow 
arrow) to the microvessel. In the choroid plexus of 21-day controls (B), LRP-1 labeling appears throughout the cytoplasm of 
epithelial cells but seems more intense on the apical surface adjacent to CSF. In 21-day hydrocephalic animals (F), LRP-1 labe-
ling is also present throughout the cell but seems denser in central regions of the cell, which may mean that LRP-1 has translo-
cated to the nucleus. Insets show these features at higher magnification. There are minimal changes between the hydrocephalic 
animals (G, H) versus the saline controls (C, D), i.e. only a slight increase in the cortex and a slight decrease in the hippocam-
pus. In D and G, the insets represent a higher magnification to show the punctate character of some LRP-1 labeling. Scale bar = 
25 μm.Cerebrospinal Fluid Research 2009, 6:4 http://www.cerebrospinalfluidresearch.com/content/6/1/4
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In contrast, we did not observe Aβ in the cerebral cortex
and hippocampus of our saline-control or hydrocephalic
21-day post-kaolin animals. LRP-1 was increased slightly
in the cerebral cortex but decreased slightly in the hippoc-
ampus of hydrocephalic animals. RAGE however, showed
opposite results in that it was decreased slightly in the cor-
tex and there was no change seen in the hippocampus
between the saline and hydrocephalic animals. This pat-
tern differs from what has been described in the adult ani-
mal studies.
Age-related changes
The most plausible explanation for the differences
between our data and the findings of Silverberg, Klinge,
and colleagues[15,48] is the age of the animals. In the
adult studies, the animals were at least 1 year old, whereas
our animals were only 3 weeks old. This age differential
becomes important when one considers the maturation of
protein clearance mechanisms. In the mature brain, Aβ is
produced constantly, but is cleared rapidly in a normal
working system where interstitial fluid concentration
remains about 10–12 nM. The system is a bidirectional
concentration-dependent flux across the blood brain bar-
rier (BBB). When that system is intact, Aβ will not accu-
mulate even if the CSF pathway is compromised. It is only
when the BBB transporters are altered with age or disease
that Aβ accumulates. Microvascular LRP-1 expression
must be reduced and RAGE expression increased in order
for Aβ to build up in the brain parenchyma. Silverberg et
al  have also observed very little Aβ accumulation in 3
month old rats (personal communication). Likewise, very
little Aβ accumulation has been noted in young dogs[49].
Therefore, our results in immature animals are consistent
with preliminary data from other labs.
The age differential is also important because the effects of
hydrocephalus may be very different in immature brains
compared to adults. The postnatal period from one day to
Photomicrographs representing RAGE immunohistochemistry of a positive control (adult control animal that is positively  stained with RAGE; A), 21-day saline controls (B, C, D), and age-matched hydrocephalic animals (E, F, G) Figure 5
Photomicrographs representing RAGE immunohistochemistry of a positive control (adult control animal that 
is positively stained with RAGE; A), 21-day saline controls (B, C, D), and age-matched hydrocephalic animals 
(E, F, G). Arrows represent blood vessels that are positively stained with RAGE proteins, characterized by either dark brown 
punctate particles (A, C, D, G) or diffused profiles (B, E). The asterisks represent non-specific staining of neuron and glial cell 
bodies. At higher magnification (inset), positive RAGE labeling can be seen within the endothelial lining (arrow) of a capillary 
deep within the hippocampus. In the choroid plexus of 21-day controls (B), RAGE labeling appears throughout the cytoplasm 
of epithelial cells but seems more intense on the apical surface adjacent to CSF. In 21-day hydrocephalic animals (E), RAGE 
labeling is also present throughout the cell but seems to have translocated to the nucleus. Insets show these features at higher 
magnification. There are minimal differences between the hydrocephalic animals (F, G) versus the saline controls (C, D), i.e. 
only a slight decrease in the cortex and no change in the hippocampus. In C, D and G, the insets represent a higher magnifica-
tion to show the punctate character of some RAGE labeling. Scale bar = 25 μm for all panels.Cerebrospinal Fluid Research 2009, 6:4 http://www.cerebrospinalfluidresearch.com/content/6/1/4
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2 weeks is a watershed period for CSF formation (hydro-
dynamics)[50] by choroid plexus and re-absorptive open-
ings in the arachnoid. Consequently, there are many
changing endogenous variables throughout our experi-
mental period. The CSF sink action[51], which plays a
prominent role in aging rats, hardly exists in neonatal rats
but it increases progressively from 0–3 days post-partum.
Thus, kaolin injection resulting in ventriculomegaly just
after birth could alter the normal development of CSF
pathways and fluid kinetics.
Finally, it is possible that since plasma Aβ concentration
is lower in infants than in adults there is a smaller concen-
tration gradient for Aβ to diffuse from plasma to the brain.
Furthermore, degradative pathways for Aβ may be upreg-
ulated in immature brains. For example, neprilysin and
insulin degrading enzyme contribute to Aβ clearance in
adult brains[52], it is not known if this pathway plays a
more prominent role in developing brains.
The positive Aβ and LRP-1 staining for choroid plexus is
interesting and suggests that the plexus is removing Aβ
from CSF of hydrocephalic animals[13], which could
explain the lack of Aβ staining in the hydrocephalic brain.
GFAP expression
Gliosis is commonly found throughout the brain in ani-
mals with severe hydrocephalus[2,27]. Increases in GFAP
and Aβ are commonly found together in adult brains with
neurological deficits[17-21,21-24]. Qiao et al. [25],
Funato et al[21] and Sasaki et al[53] state that there is a
possibility that astrocytes engulf Aβ diffused plaques and
attempt to degrade them in lysosomes in the aged brain.
Qiao et al[25] found that neuroinflammation can acceler-
ate amyloid deposition in mice and Nagele et al[24] sug-
gest that Aβ-burdened neurons and astrocytes appear to
make a major contribution to observed amyloid plaques
in the brain. These studies point out that where there is an
accumulation of reactive astrocytes in an aged brain one
will find an accumulation of Aβ. In contrast, our hydro-
cephalic rats exhibited large amounts of reactive astrocytes
but no appearance of Aβ. Therefore, we cannot make the
same correlation for our younger animals. Our findings
suggest that reactive astrocytosis may not be directly
involved in protein clearance, or that other factors such as
neuronal damage, ischemia, edema or intraparenchymal
pressure may trigger an independent response in astro-
cytes.
Representative immunohistochemical images of anti-GFAP staining Figure 6
Representative immunohistochemical images of anti-GFAP staining. The positive control (A) is provided to illus-
trate typical staining characteristics. The hydrocephalic cortex and hippocampus contain severe reactive astrocytosis (F and G 
respectively) when compared to their age-matched saline controls (C and D). The choroid plexus B and E in both groups were 
negative for GFAP. Arrows = reactive astrocytes, scale bar = 25 μm.
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Conclusion
In neonatal hydrocephalic animals, immunohistochemi-
cal staining demonstrated levels of Aβ, RAGE, and LRP-1
that were substantially lower than those seen in adult
hydrocephalic animals, while GFAP levels were elevated
in both groups. Immunohistochemistry and qRT-PCR in
neonatal rats revealed no significant change in Aβ, LRP-1
and RAGE between the hydrocephalic animals and age-
matched controls. However, statistically significant
increases in GFAP gene expression did occur in the hydro-
cephalic animals.
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Quantitative RT-PCR: The histograms represent quantitative results from the real time RT-PCR analysis Figure 7
Quantitative RT-PCR: The histograms represent quantitative results from the real time RT-PCR analysis. The 
data indicate a significant increase in GFAP in both the parietal cortex and hippocampus of the hydrocephalic animals versus 
the age-matched controls. No significant differences were seen in LRP-1 and RAGE in the parietal cortex and hippocampus. 
The means are expressed as percent change versus control plus or minus the standard error of the mean. N= 5 for each group 
and statistical significance is defined as P < 0.05.
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Table 1: Summary of relative changes in expression of A-beta protein (Aβ), low-density lipoprotein receptor-related protein (LRP-1), 
receptor for advanced glycation end products (RAGE) and glial fibrillary acidic protein (GFAP) in brain tissue from control and 
hydrocephalic rats. 
Adult
Hydro vs. Control
IHC
Neonatal
Hydro vs. Control
IHC/qRT-PCR
Adult Control
vs.
Neonatal Control
IHC
Adult Hydro
vs.
Neonatal Hydro
IHC
Aβ Increase NC/NA NC Decrease
LRP-1 Decrease NC/NC Decrease NC
RAGE Increase NC/NC Decrease Decrease
GFAP Increase Increase/Increase NC NC
IHC: immunohistochemistry; qRT-PCR: quantitative RT- PCR; NC- no change; NA-not applicable. Results from cortex and hippocampus have been 
combined.Cerebrospinal Fluid Research 2009, 6:4 http://www.cerebrospinalfluidresearch.com/content/6/1/4
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